Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

AMOT activates USP9X. 3 / 3

| 3

➶

reach

"Moreover, previous studies showed that USP9X targets Angiomotin (AMOT) and Angiomotin like 2 (AMOTL2), which in turn regulates YAP1 activation XREF_BIBR, XREF_BIBR."

29449692

➶

reach

"USP9x targets AMOT and AMOT like proteins."

27462448

➶

reach

"On the other hand, overexpression of AMOT could not rescue cancer cell growth in USP9X depleted cells (XREF_SUPPLEMENTARY)."

29449692

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

AMOT activates USP9X. 3 / 3

Our Sources:

Databases

Reading